Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -2,369 | -1,009 | -2,038 | -940 |
| Depreciation Amortization | 105 | 50 | 145 | 99 |
| Accounts receivable | -265 | -229 | N/A | 133 |
| Accounts payable and accrued liabilities | 104 | N/A | N/A | N/A |
| Other Working Capital | -502 | 1,088 | 220 | 142 |
| Other Operating Activity | 671 | 382 | 492 | 168 |
| Operating Cash Flow | $-2,257 | $281 | $-1,181 | $-398 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -186 | -149 | -289 | -179 |
| Other Investing Activity | 6 | 6 | -22 | -22 |
| Investing Cash Flow | $-180 | $-142 | $-311 | $-201 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 2,640 | N/A | N/A | 515 |
| Other Financing Activity | -112 | -92 | 1,000 | 0 |
| Financing Cash Flow | $2,528 | $-92 | $1,000 | $515 |
| Beginning Cash Position | 67 | 67 | 559 | 559 |
| End Cash Position | 158 | 114 | 67 | 475 |
| Net Cash Flow | $92 | $47 | $-492 | $-84 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,257 | 281 | -1,181 | -398 |
| Capital Expenditure | -186 | -149 | N/A | -179 |
| Free Cash Flow | -2,443 | 132 | -1,181 | -577 |